| Year |
Citation |
Score |
| 2022 |
Narayanan S, Dai D, Vyas Devambatla RK, Albert V, Bruneau-Latour N, Vasukuttan V, Ciblat S, Rehder K, Runyon SP, Maitra R. Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor. Bioorganic & Medicinal Chemistry. 66: 116789. PMID 35594649 DOI: 10.1016/j.bmc.2022.116789 |
0.347 |
|
| 2021 |
Narayanan S, Wang S, Vasukuttan V, Vyas Devambatla RK, Dai D, Jin C, Snyder R, Laudermilk L, Runyon SP, Maitra R. Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice. Journal of Medicinal Chemistry. PMID 33705126 DOI: 10.1021/acs.jmedchem.0c01448 |
0.312 |
|
| 2019 |
Narayanan S, Vasukuttan V, Rajagopal S, Maitra R, Runyon SP. Identification of potent pyrazole based APELIN receptor (APJ) agonists. Bioorganic & Medicinal Chemistry. 115237. PMID 31948845 DOI: 10.1016/J.Bmc.2019.115237 |
0.411 |
|
| 2016 |
Narayanan S, Maitra R, Deschamps JR, Bortoff K, Thomas JB, Zhang Y, Warner K, Vasukuttan V, Decker A, Runyon SP. Discovery of a novel small molecule agonist scaffold for the APJ receptor. Bioorganic & Medicinal Chemistry. PMID 27369451 DOI: 10.1016/J.Bmc.2016.06.018 |
0.39 |
|
| 2016 |
Katz JL, Hiranita T, Kopajtic TA, Rice KC, Mesangeau C, Narayanan S, Abdelazeem AH, McCurdy CR. Blockade of Cocaine or Sigma Receptor Agonist Self-Administration by Subtype- Selective Sigma Receptor Antagonists. The Journal of Pharmacology and Experimental Therapeutics. PMID 27189970 DOI: 10.1124/Jpet.116.232728 |
0.629 |
|
| 2015 |
Thomas JB, Giddings AM, Olepu S, Wiethe RW, Harris DL, Narayanan S, Warner KR, Sarret P, Longpre JM, Runyon SP, Gilmour BP. Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2. Bioorganic & Medicinal Chemistry Letters. 25: 292-6. PMID 25499438 DOI: 10.1016/J.Bmcl.2014.11.047 |
0.351 |
|
| 2014 |
Buzard DJ, Kim SH, Lehmann J, Han S, Calderon I, Wong A, Kawasaki A, Narayanan S, Bhat R, Gharbaoui T, Lopez L, Yue D, Whelan K, Al-Shamma H, Unett DJ, et al. Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24: 4332-5. PMID 25088191 DOI: 10.1016/J.Bmcl.2014.06.071 |
0.521 |
|
| 2011 |
Kaushal N, Robson MJ, Vinnakota H, Narayanan S, Avery BA, McCurdy CR, Matsumoto RR. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. The Aaps Journal. 13: 336-46. PMID 21494909 DOI: 10.1208/S12248-011-9274-9 |
0.624 |
|
| 2011 |
Narayanan S, Bhat R, Mesangeau C, Poupaert JH, McCurdy CR. Early development of sigma-receptor ligands. Future Medicinal Chemistry. 3: 79-94. PMID 21428827 DOI: 10.4155/Fmc.10.279 |
0.648 |
|
| 2011 |
Narayanan S, Mesangeau C, Poupaert JH, McCurdy CR. Sigma receptors and cocaine abuse. Current Topics in Medicinal Chemistry. 11: 1128-50. PMID 21050176 DOI: 10.2174/156802611795371323 |
0.664 |
|
| 2011 |
Garcés-RamÃrez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biological Psychiatry. 69: 208-17. PMID 20950794 DOI: 10.1016/J.Biopsych.2010.07.026 |
0.668 |
|
| 2008 |
Mésangeau C, Narayanan S, Green AM, Shaikh J, Kaushal N, Viard E, Xu YT, Fishback JA, Poupaert JH, Matsumoto RR, McCurdy CR. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity. Journal of Medicinal Chemistry. 51: 1482-6. PMID 18278854 DOI: 10.1021/Jm701357M |
0.654 |
|
| 2008 |
Fishback jA, Mesangeau C, Narayanan S, McCurdy CR, Matsumoto RR. Novel Radioligands for Sigma‐1 Receptor Binding Studies The Faseb Journal. 22: 628-628. DOI: 10.1096/Fasebj.22.2_Supplement.628 |
0.591 |
|
| Show low-probability matches. |